Science
Five papers suggested by Arndt Vogel

Five papers suggested by Arndt Vogel

Arndt Vogel, MD, is a Managing Senior Consultant and a Professor in the Department of Gastroenterology, Hepatology, and Endocrinology at Hannover Medical School. Leading the GI-Cancer Center and the Center for Personalized Medicine, his research focuses on translational and clinical studies in gastrointestinal cancer. He’s actively engaged in various societies including ESMO, ASCO, and EASL. Additionally, he chairs the Hepatobiliary Cancer Study Group of the AIO, contributing significantly to clinical oncology in Germany. Within ESMO, he serves on the Guidelines Steering Committee.

ESMO

He suggested following few must-read papers on X:

1. SWOG S1815: A Phase III Randomized Trial of Gemcitabine, Cisplatin, and Nab-Paclitaxel Versus Gemcitabine and Cisplatin in Newly Diagnosed, Advanced Biliary Tract Cancers

Authors:  Rachna T. Shroff et al.

3. Stereotactic Body Radiotherapy vs Sorafenib Alone in Hepatocellular Carcinoma The NRG Oncology/RTOG 1112 Phase 3 Randomized Clinical Trial

Authors: Laura A. Dawson et al.

4. A Model for Decoding Resistance in Precision Oncology: Acquired Resistance to FGFR inhibitors in Cholangiocarcinoma

Authors: L. Goyal et al.

5. Pancreatic Cancer Surveillance and Survival of High-Risk Individuals

Authors: Amanda L. Blackford et al.

More Posts Featuring Arndt Vogel.

Amanda L. Blackford Arndt Vogel Biliary tract cancer cancer cholangiocarcinoma Daniel Q. Huang ESMO Clinical Practice Guideline Hannover Medical School hepatocellular carcinoma Laura A Dawson Luan C.V. Lima Lubna Al-Sharif Matheus Souza OncoDaily Oncology Pancreatic Cancer Rachna T. Shroff